L&G Pharma Breakthrough UCITS ETF • BIOT

Capital at risk.

About L&G Pharma Breakthrough UCITS ETF
Base currency
info
$ USD
Traded currency
info
GBX
ISIN
info
IE00BF0H7608
Trading on
info
LSE
Ticker
info
BIOT
Fund manager
info
Legal & General
Key facts & metrics
BasicAdvanced
Fund size
info
£20.9M
Income
info
Distributing
Expense Ratio
info
49.00%
Dividend Yield
info
1.02578
Valuation
Price to prospective earnings
info
13.5
Price to book
info
1.95
Price to sales
info
2.26
Price to cashflow
info
9.34
Price
52-week High
info
GBX 878.04
52-week Low
info
GBX 705.20
50-day moving average
info
GBX 786.53
200-day moving average
info
GBX 811.33
Technicals
YTD
info
7.55%
Year 1
info
8.87%
Year 3
info
-1.87%
Year 5
info
-2.84%
Year 10
info
0.00%
Volatility Year 1
info
14.80%
Volatility Year 3
info
14.90%
Expected Return Year 3
info
0.00%
Sharpe Ratio
info
-0.33%
Growth
Long term projected earnings
info
7.06%
Historical earnings
info
2.81%
Sales
info
2.21%
Cash flow
info
11.83%
Book value
info
6.43%
Sector breakdown
sector logo

Healthcare

% 94,24

sector logo

Materials

% 5,76

Regional breakdown

North America

% 60,17

Asia

% 20,50

Europe

% 16,88

UK

% 2,45

Top 10 Holdings
provider logo
Innocare Pharma Ltd

3.8%

provider logo
Alnylam Pharmaceuticals

3.71%

provider logo
Pharming Group NV

3.49%

provider logo
Ionis Pharmaceuticals Inc

3.47%

provider logo
KemPharm Inc

3.28%

provider logo
BioCryst Pharmaceuticals Inc

3.17%

provider logo
Kyowa Kirin Co Ltd

3.14%

provider logo
LG Chemicals

3.06%

provider logo
Xeris Pharmaceuticals Inc

3.06%

provider logo
Royalty Pharma Plc

3.01%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

What is the name of BIOT?
Collapse

The name of BIOT is L&G Pharma Breakthrough UCITS ETF.

What is the ticker of L&G Pharma Breakthrough UCITS ETF?
Collapse

The primary ticker of L&G Pharma Breakthrough UCITS ETF is BIOT.

What is the ISIN of L&G Pharma Breakthrough UCITS ETF?
Collapse

The ISIN of L&G Pharma Breakthrough UCITS ETF is IE00BF0H7608.

What are the costs of L&G Pharma Breakthrough UCITS ETF
Collapse

The total expense ratio (TER) of L&G Pharma Breakthrough UCITS ETF amounts to 49.00% p.a. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately.

Does L&G Pharma Breakthrough UCITS ETF pay dividends?
Collapse

Yes, L&G Pharma Breakthrough UCITS ETF does pay dividends.

What currency is L&G Pharma Breakthrough UCITS ETF traded in?
Collapse

L&G Pharma Breakthrough UCITS ETF is traded in GBX.

Is L&G Pharma Breakthrough UCITS ETF an accumulating or distributing ETF?
Collapse

L&G Pharma Breakthrough UCITS ETF is distributing.

Who is the fund manager of “L&G Pharma Breakthrough UCITS ETF?
Collapse

The fund manager of L&G Pharma Breakthrough UCITS ETF is Legal & General.

What is the fund size of L&G Pharma Breakthrough UCITS ETF?
Collapse

The fund size of L&G Pharma Breakthrough UCITS ETF is £20.9M.